Based on the provided search results, no relevant information about "REM19 Antibody" was identified in the scientific literature or clinical research records. The cited studies discuss other monoclonal antibodies (e.g., MW05, MW07) and general immunogenicity testing methodologies, but no data exist for REM19 in these sources. Below is a template structure for antibody research FAQs that could be adapted if additional information becomes available:
Introduce LALA mutations (Leu234Ala/Leu235Ala) to eliminate FcγR binding while retaining neutralization capacity
Compare ADE activity in THP-1 vs. Raji cell lines with flow cytometry quantification
| Discrepancy Source | Resolution Approach |
|---|---|
| Conformational epitopes | Cryo-EM structural validation |
| ACE2 expression levels | Parallel testing in 293T (high ACE2) vs. A549 (low ACE2) |